» Articles » PMID: 18385732

Imaging in the Era of Molecular Oncology

Overview
Journal Nature
Specialty Science
Date 2008 Apr 4
PMID 18385732
Citations 716
Authors
Affiliations
Soon will be listed here.
Abstract

New technologies for imaging molecules, particularly optical technologies, are increasingly being used to understand the complexity, diversity and in vivo behaviour of cancers. 'Omic' approaches are providing comprehensive 'snapshots' of biological indicators, or biomarkers, of cancer, but imaging can take this information a step further, showing the activity of these markers in vivo and how their location changes over time. Advances in experimental and clinical imaging are likely to improve how cancer is understood at a systems level and, ultimately, should enable doctors not only to locate tumours but also to assess the activity of the biological processes within these tumours and to provide 'on the spot' treatment.

Citing Articles

From detection to elimination: iron-based nanomaterials driving tumor imaging and advanced therapies.

Xie D, Sun L, Wu M, Li Q Front Oncol. 2025; 15:1536779.

PMID: 39990682 PMC: 11842268. DOI: 10.3389/fonc.2025.1536779.


A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis.

Azimizonuzi H, Ghayourvahdat A, Ahmed M, Kareem R, Jaber Zrzor A, Mansoor A Cancer Cell Int. 2025; 25(1):26.

PMID: 39871316 PMC: 11773959. DOI: 10.1186/s12935-024-03610-z.


Fluorescent Particles Based on Aggregation-Induced Emission for Optical Diagnostics of the Central Nervous System.

Liu S, Liu J, Li X, Du X, Yin C, Luo Y Research (Wash D C). 2025; 8:0564.

PMID: 39866911 PMC: 11757665. DOI: 10.34133/research.0564.


Optical molecular imaging technology and its application in precise surgical navigation of liver cancer.

He P, Tang H, Zheng Y, Xu X, Peng X, Jiang T Theranostics. 2025; 15(3):1017-1034.

PMID: 39776802 PMC: 11700863. DOI: 10.7150/thno.102671.


Infrared thermal modulation endoscopy for label-free tumor detection.

Kim S, Oh G, Ro Kim Y, Chung E, Kwon H Sci Rep. 2024; 14(1):31575.

PMID: 39738048 PMC: 11685564. DOI: 10.1038/s41598-024-76173-8.


References
1.
Ventura A, Kirsch D, McLaughlin M, Tuveson D, Grimm J, Lintault L . Restoration of p53 function leads to tumour regression in vivo. Nature. 2007; 445(7128):661-5. DOI: 10.1038/nature05541. View

2.
Roberti M, Bertoncini C, Klement R, Jares-Erijman E, Jovin T . Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat Methods. 2007; 4(4):345-51. DOI: 10.1038/nmeth1026. View

3.
Tatsuta M, Iishi H, Ichii M, Baba M, Yamamoto R, Okuda S . Diagnosis of gastric cancers with fluorescein-labeled monoclonal antibodies to carcinoembryonic antigen. Lasers Surg Med. 1989; 9(4):422-6. DOI: 10.1002/lsm.1900090415. View

4.
Pittet M, Swirski F, Reynolds F, Josephson L, Weissleder R . Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nat Protoc. 2007; 1(1):73-9. DOI: 10.1038/nprot.2006.11. View

5.
Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View